GLP-1 Market
LLY $1434.34 ▼ -0.2% NVO $40.56 ▼ -1.3% PFE $28.93 ▼ -1.7% VKTX $27.71 ▼ -2.5% KLRA $13.31 ▼ -7.4% GPCR $19.89 ▼ -5.1% RHHBY $60.57 ▼ -0.8%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Dextrose 20%

Company
David D'Alessio, M.D.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
5 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

5 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 12, 2026

Find a Clinical Trial Near Me

See recruiting studies for Dextrose 20% and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04832009

    Reversing Glucose and Lipid-mediated Vascular Dysfunction

    Not yet reported University of Kansas Medical Center 46 participants Est. completion 2027-08-01 1 site
    Other conditions: Blood Pressure, Hypertension
    View official trial listing →
  • Recruiting NCT NCT06126419

    Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 70 participants Est. completion 2026-12 1 site
    Other conditions: Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration
    View official trial listing →
  • Recruiting NCT NCT07224334

    Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.

    Not yet reported David D'Alessio, M.D. 30 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Diabetes (DM)
    View official trial listing →
  • Recruiting NCT NCT07403604

    Effect of Insulin Lowering on Lipogenesis

    Not yet reported Columbia University 25 participants Est. completion 2029-09-30 1 site
    Other conditions: Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease, Prediabetic State, Obesity
    View official trial listing →
  • Recruiting NCT NCT07778524

    Alpelisib Challenge Test (ACT)

    Not yet reported Columbia University 15 participants Est. completion 2028-08-31 1 site Stand-alone
    Type 2 diabetes Other conditions: Insulin Resistance, Obesity & Overweight, Healthy Adult Participants
    View official trial listing →
  • Status unknown NCT NCT01001273

    Hyperinsulinemic Normoglycemic Clamp for Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 80 participants Est. completion 2012-06 1 site
    Other conditions: Postoperative Complications
    View official trial listing →
  • Completed NCT NCT01187329

    The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose

    Not yet reported The Cleveland Clinic 100 participants Est. completion 2013-12 1 site
    Other conditions: Hyperglycemia, Aortic Valve Replacement, Aortic Stenosis, Cardiac Surgery
    View official trial listing →
  • Completed NCT NCT01528189

    Effect of High Dose Insulin on Infectious Complications Following Major Surgery

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 480 participants Est. completion 2025-09-01 3 sites
    Other conditions: Surgical Site Infection After Major Surgery
    View official trial listing →
  • Completed NCT NCT01706172

    Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection

    Not yet reported, Not yet reported Chisel Peak Medical Clinic 42 participants Est. completion 2016-06 1 site
    Other conditions: Temporomandibular Joint Disorders
    View official trial listing →
  • Completed NCT NCT01934868

    Prolotherapy Versus Epidural Steroid Injections (ESI) for Lumbar Pain Radiating to the Leg

    Not yet reported Hadassah Medical Organization 110 participants Est. completion 2023-04-10 1 site
    Obstructive sleep apnea Other conditions: Sciatica, Spinal Stenosis of Lumbar Region
    View official trial listing →
  • Withdrawn NCT NCT02032953

    Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre Est. completion 2024-04 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02053935

    Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects

    Not yet reported Albert Einstein College of Medicine 15 participants Est. completion 2016-01 1 site
    Other conditions: Hyperglycemia, Sepsis
    View official trial listing →
  • Withdrawn NCT NCT02102243

    Neural Mechanism of Aldosterone-induced Insulin Resistance

    Not yet reported Wanpen Vongpatanasin Est. completion 2025-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02269735

    A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)

    Not yet reported Merck Sharp & Dohme LLC 74 participants Est. completion 2016-07-29
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02549443

    The Anabolic Effect Of Perioperative Nutrition With Insulin In Patients Undergoing CABG

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 30 participants Est. completion 2015-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02746432

    Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial

    Not yet reported King Saud University 144 participants Est. completion 2021-03 1 site
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT03520569

    Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

    Not yet reported University of Virginia 15 participants Est. completion 2021-04-01 1 site
    Other conditions: Vascular Stiffness, Insulin Sensitivity
    View official trial listing →
  • Withdrawn NCT NCT04133922

    Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

    Not yet reported University of Virginia Est. completion 2024-10 1 site
    Other conditions: Type 1 Diabetes, Insulin Sensitivity/Resistance
    View official trial listing →
  • Suspended NCT NCT04207619

    Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation

    Not yet reported Pennington Biomedical Research Center 10 participants Est. completion 2027-10 1 site
    Other conditions: Diabetes, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT06592261

    Graded Insulin Suppression Test P&F

    Not yet reported Columbia University 20 participants Est. completion 2026-10-13 1 site
    Other conditions: Insulin Resistance, Hyperinsulinemia, Obesity, Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT06839430

    Therapeutic Effect of Using Injectable Hypertonic Saline 5% Versus Injectable Dextrose 20% on Pain in Painful Cases of Disc Displacement With Reduction

    Not yet reported Cairo University 20 participants Est. completion 2026-09-20
    Other conditions: TMJ Disc Displacement With Reduction
    View official trial listing →
  • Not yet recruiting NCT NCT07688096

    Regenerative Medicine for Joint Hypermobility and Instability

    Not yet reported, Not yet reported Manhattan Pain Medicine, PLLC 100 participants Est. completion 2028-12-31
    Other conditions: Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS), Joint Hypermobility, Joint Instability, Hypermobility Spectrum Disorder, Chronic Pain Syndrome, Musculoskeletal Pain, Sprain, Subluxation, Dislocation, Craniocervical Disfunction
    View official trial listing →
  • Active, not recruiting NCT NCT07798258

    Assessment of Injectable PRF Versus Dextrose Injection in Temporomandibular Joint in Anterior Disc Displacement With Reduction

    Not yet reported Cairo University 24 participants Est. completion 2027-02-10 1 site
    Other conditions: TMD
    View official trial listing →
  • Not yet recruiting NCT NCT07901348

    GENIVS Block Versus Adductor Canal Block After Total Knee Arthroplasty

    Not yet reported Bakirkoy Dr. Sadi Konuk Research and Training Hospital 74 participants Est. completion 2027-06-01 1 site
    Osteoarthritis Other conditions: Arthroplasty, Replacement, Knee, Pain, Postoperative
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Dextrose 20%, Dextrose 20% solution

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.